Company Refocus Group, Inc. Other OTC
Equities
RFCS
US75865X2027
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
J. Michael Judy
CEO | Chief Executive Officer | - | 13-10-27 |
David Schanzlin
CTO | Chief Tech/Sci/R&D Officer | - | 12-01-31 |
Selene A. Burke
CTO | Chief Tech/Sci/R&D Officer | - | 05-12-31 |
David G. Ozinga
PRN | Corporate Officer/Principal | - | 07-12-31 |
Corporate Officer/Principal | - | 02-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 10-12-31 | |
Thomas M. Loarie
CHM | Chairman | - | 13-12-31 |
Thomas Lyles
BRD | Director/Board Member | - | 05-02-28 |
J. Michael Judy
CEO | Chief Executive Officer | - | 13-10-27 |
Donald Phillips
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,669,105 | 24,669,105 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 760,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |